A Study of Degarelix in Taiwanese Patients With Prostate Cancer
NCT01220869
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
110
Enrollment
INDUSTRY
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
Degarelix
Sponsor
Ferring Pharmaceuticals